
Triple-receptor research peptide (GLP-1/GIP/glucagon). Lyophilised vial for reconstitution.

40mg
Dual GIP/GLP-1 receptor agonist research peptide. Lyophilised vial for reconstitution.
Order by 12pm on a business day — ships same day.
A typical dose referenced in published research literature is 2.5 mg starting dose, escalating to a 5–15 mg weekly maintenance dose, administered subcutaneously once weekly — the step-wise titration schedule used across the Phase 3 SURPASS and SURMOUNT trials to limit GI side effects.
TR-GLP2 is our coded name for Tirzepatide (Eli Lilly LY3298176, sometimes shortened to Tirze) — a dual GIP/GLP-1 receptor agonist and one of the most extensively studied incretin compounds in the literature, marketed by Eli Lilly as Mounjaro and Zepbound.
In the SURMOUNT-1 trial, participants achieved up to 22.5% mean body-weight reduction at the highest dose; the SURPASS trial programme reported HbA1c reductions of up to 2.58%, both cited across the incretin literature as best-in-class figures for this drug family.
This vial ships lyophilised for reconstitution, strictly for laboratory and research use. For the full mechanism and trial-by-trial breakdown, see our Tirzepatide research profile.
| Component | Mass | Research profile | Profile |
|---|---|---|---|
| Tirzepatide | 40 mg | Dual GIP/GLP-1 receptor agonist research | Wiki → |
A manufacturer's own purity figure is not independent verification. Every batch we sell is tested by an independent laboratory before it is offered.
View CoA (certificate of analysis)Independent published research on this material. We link to the source rather than summarising it.
Tirzepatide carries an FDA boxed warning: it caused dose-dependent thyroid C-cell tumours in rodent studies, and it is not known whether it does the same in humans. It is contraindicated for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome. Post-marketing surveillance has also logged reports of suicidal ideation in patients on GLP-1 receptor agonists including tirzepatide; as of 2025 the FDA found the evidence did not establish a causal link, and both the FDA and EMA continue to monitor it. We would rather you read the trial data yourself than take our summary of it.
| Unreconstituted powder | |
|---|---|
| −20 °C | 24 months |
| 2–8 °C | 6 months |
| Room temperature | Caution — only 30 days |
| Reconstituted solution | |
| Below 0 °C | Do not use. Discard |
| 2–8 °C | 35 days |
| +15 °C | Caution — only 7 days |
| +30 °C | Do not use. 24 hours |
Once reconstituted, keep at 2–8 °C and use within 35 days.
Never freeze a reconstituted vial — a frozen solution is spoiled.
Our calculator opens pre-filled for the selected vial — enter your target dose and it returns the draw in units.
Open the calculatorGood packaging, fast shipping. Arrived next day.
Fast reply, no fuss
Order confirm within minutes on WhatsApp, no need chase them at all. Whole process super smooth!
Lambat sikit sebab cuti umum tapi diorang update selalu, so tak risau sangat. Overall ok je!
Second time already ordering here, still smooth like first round! Tracking also work this time, can see parcel moving.
Reply fast one!
Ask a few questions before ordering, they reply on WhatsApp quick! Not those copy-paste answer, genuinely helpful.
Sampai dengan selamat
Risau jugak tadi takut rosak masa penghantaran tapi packing memang kemas, semua sampai dalam keadaan baik. Bagus!
First time order, a bit shy to ask so many questions but they explain everything patiently. WhatsApp summary matches what I expect to pay, no surprise charges!
Payment instructions clear, order confirm same day itself. No extra charges appear last minute, appreciate that!
Kawan recommend, so try lah. Courier update pun datang betul-betul, rasa memang profesional cara diorang buat.
No issue even in Sabah
Thought will take longer since I'm in Sabah but arrived within few days only. Packing sturdy enough for the distance, good stuff.

Triple-receptor research peptide (GLP-1/GIP/glucagon). Lyophilised vial for reconstitution.